These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27574420)

  • 1. Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii.
    Wan G; Ruan L; Yin Y; Yang T; Ge M; Cheng X
    Int J Nanomedicine; 2016; 11():3789-800. PubMed ID: 27574420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Multifunctional Silver Nanocomposite Serves as a Resistance-Reversal Agent to Synergistically Combat Carbapenem-Resistant
    Li X; Gui R; Li J; Huang R; Shang Y; Zhao Q; Liu H; Jiang H; Shang X; Wu X; Nie X
    ACS Appl Mater Interfaces; 2021 Jul; 13(26):30434-30457. PubMed ID: 34161080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biogenic silver nanoparticle (Bio-AgNP) has an antibacterial effect against carbapenem-resistant Acinetobacter baumannii with synergism and additivity when combined with polymyxin B.
    Allend SO; Garcia MO; da Cunha KF; de Albernaz DTF; da Silva ME; Ishikame RY; Panagio LA; Nakazaro G; Reis GF; Pereira DB; Hartwig DD
    J Appl Microbiol; 2022 Feb; 132(2):1036-1047. PubMed ID: 34496109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efflux pump inhibitory activity of biologically synthesized silver nanoparticles against multidrug-resistant Acinetobacter baumannii clinical isolates.
    Behdad R; Pargol M; Mirzaie A; Karizi SZ; Noorbazargan H; Akbarzadeh I
    J Basic Microbiol; 2020 Jun; 60(6):494-507. PubMed ID: 32301139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial Activities of Bacteriagenic Silver Nanoparticles Against Nosocomial
    Singh R; Vora J; Nadhe SB; Wadhwani SA; Shedbalkar UU; Chopade BA
    J Nanosci Nanotechnol; 2018 Jun; 18(6):3806-3815. PubMed ID: 29442713
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.
    Hong DJ; Kim JO; Lee H; Yoon EJ; Jeong SH; Yong D; Lee K
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):184-9. PubMed ID: 27475960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synergic and addictive activity of biogenic silver nanoparticle associated with meropenem against carbapenem-resistant Acinetobacter baumannii.
    Allend SO; Oliveira Garcia M; da Cunha KF; de Albernaz DTF; Panagio LA; Nakazaro G; Reis GF; Oliveira TL; Neto ACPS; Hartwig DD
    J Appl Microbiol; 2024 Mar; 135(3):. PubMed ID: 38383758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
    Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F
    J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
    Lee S; Razqan GS; Kwon DH
    Phytomedicine; 2017 Jan; 24():49-55. PubMed ID: 28160861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity of silver nanoparticles against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Shah AA; Ahmad I; Shafique M; Siddique AB; Aslam B; Qamar MU
    Pak J Pharm Sci; 2022 Jan; 35(1(Supplementary)):203-208. PubMed ID: 35228178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii.
    Hetta HF; Al-Kadmy IMS; Khazaal SS; Abbas S; Suhail A; El-Mokhtar MA; Ellah NHA; Ahmed EA; Abd-Ellatief RB; El-Masry EA; Batiha GE; Elkady AA; Mohamed NA; Algammal AM
    Sci Rep; 2021 May; 11(1):10751. PubMed ID: 34031472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of silver nanoparticles (Axonnite) on clinical and environmental strains of Acinetobacter spp.
    Łysakowska ME; Ciebiada-Adamiec A; Klimek L; Sienkiewicz M
    Burns; 2015 Mar; 41(2):364-71. PubMed ID: 25145873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
    Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J
    J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection.
    Huang Y; Wiradharma N; Xu K; Ji Z; Bi S; Li L; Yang YY; Fan W
    Biomaterials; 2012 Dec; 33(34):8841-7. PubMed ID: 22925814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Efficacy of Imipenem Conjugated with Synthesized Silver Nanoparticles Against Acinetobacter baumannii Clinical Isolates, Iran.
    Zendegani E; Dolatabadi S
    Biol Trace Elem Res; 2020 Sep; 197(1):330-340. PubMed ID: 31701463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethyl chitosan-capped silver nanoparticles with positive surface charge: Their catalytic activity and antibacterial spectrum including multidrug-resistant strains of Acinetobacter baumannii.
    Chang TY; Chen CC; Cheng KM; Chin CY; Chen YH; Chen XA; Sun JR; Young JJ; Chiueh TS
    Colloids Surf B Biointerfaces; 2017 Jul; 155():61-70. PubMed ID: 28411476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopeptide Paenipeptin Analogues Potentiate Clarithromycin and Rifampin against Carbapenem-Resistant Pathogens.
    Moon SH; Huang E
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.